Brian Goff

Shares of Baxalta Inc (NYSE: BXLT) were trading higher by nearly 1 percent Wednesday after the company announced it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval of its ADYNOVI. Baxalta completed a study in patients aged 12 to 16...